Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (321-330 of 442) with videos related to

Pageof 45
Sort By:
Virology|April 24, 2018
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier categorySaikat Boliar, Shilpa Patil, Brihaspati N Shukla, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
Nucleic Acids Research|September 23, 2003
Evaluation of gene expression measurements from commercial microarray platformsPaul K Tan, Thomas J Downey, Edward L Spitznagel, et al.
Journal of Virology|September 19, 2008
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingKimberly A Bishop, Andrew C Hickey, Dimple Khetawat, et al.
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.
Lancet (London, England)|December 6, 2001
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyM A Polis, I A Sidorov, C Yoder, et al.
Mabs|March 11, 2016
Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1Weizao Chen, Ariola Bardhi, Yang Feng, et al.
Antiviral Research|July 11, 2013
A treatment for and vaccine against the deadly Hendra and Nipah virusesChristopher C Broder, Kai Xu, Dimitar B Nikolov, et al.
Journal of Virology|November 8, 2013
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domainsWeizao Chen, Yang Feng, Ponraj Prabakaran, et al.
Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.
Pageof 45

Showing results (321-330 of 442) with videos related to

Sort By:
Pageof 45
Virology|April 24, 2018
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier categorySaikat Boliar, Shilpa Patil, Brihaspati N Shukla, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
Nucleic Acids Research|September 23, 2003
Evaluation of gene expression measurements from commercial microarray platformsPaul K Tan, Thomas J Downey, Edward L Spitznagel, et al.
Journal of Virology|September 19, 2008
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingKimberly A Bishop, Andrew C Hickey, Dimple Khetawat, et al.
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.
Lancet (London, England)|December 6, 2001
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyM A Polis, I A Sidorov, C Yoder, et al.
Mabs|March 11, 2016
Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1Weizao Chen, Ariola Bardhi, Yang Feng, et al.
Antiviral Research|July 11, 2013
A treatment for and vaccine against the deadly Hendra and Nipah virusesChristopher C Broder, Kai Xu, Dimitar B Nikolov, et al.
Journal of Virology|November 8, 2013
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domainsWeizao Chen, Yang Feng, Ponraj Prabakaran, et al.
Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.
Pageof 45